NCT05024214 2025-05-29Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors3D MedicinesPhase 1/2 Recruiting170 enrolled
NCT05068427 2024-08-07Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.Chipscreen Biosciences, Ltd.Phase 2 Completed34 enrolled